These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9211677)

  • 1. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
    Musch DC; Martin DF; Gordon JF; Davis MD; Kuppermann BD
    N Engl J Med; 1997 Jul; 337(2):83-90. PubMed ID: 9211677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
    Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
    N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.
    Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ
    N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.
    Imai Y; Shum C; Martin DF; Kuppermann BD; Drew WL; Margolis TP
    J Infect Dis; 2004 Feb; 189(4):611-5. PubMed ID: 14767813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
    Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cytomegalovirus retinitis in acquired immunodeficiency syndrome with intravitreal ganciclovir implant.
    Tayanithi P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S142-7. PubMed ID: 11529327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M; Dunn JP
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
    Duker JS; Robinson M; Anand R; Ashton P
    Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of cytomegalovirus retinitis in AIDS with an intraocular sustained-release ganciclovir implant].
    Mochizuki M; Ikeda E; Yoshimura K; Hikita N; Nagata Y; Iwamoto A; Fujino Y; Eguchi S; Oka S; Kimura S
    Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):515-21. PubMed ID: 9754023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye implants shown superior to IV for retinitis.
    AIDS Alert; 1997 Oct; 12(10):115-7. PubMed ID: 11364717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
    Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
    Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First eye implant approved.
    AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir implants (Vitrasert).
    Treat Rev; 1996 Apr; (no 21):10. PubMed ID: 11363393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganciclovir ocular implant: new preparation. May benefit severely affected AIDS patients.
    Prescrire Int; 1998 Jun; 7(35):77-8. PubMed ID: 10342923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
    AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.